N/A
N=418
Parent Involvement in Adolescent Obesity Treatment
Pediatric Obesity
Bottom Line
View on ClinicalTrials.gov: NCT03851796 ↗Enrolled (actual)
418
Serious AEs
2.6%
Results posted
Dec 2025
Primary outcome: Primary: Body Mass Index (BMI) Change — 1.51; 0.91 kg/m^2
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TEENS+Parents as Coaches (Behavioral); TEENS+Parent Weight Loss (Behavioral)
- Age
- Pediatric · 12+ yrs
- Sex
- All
- Sponsor
- Virginia Commonwealth University
- Primary completion
- Oct 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Body Mass Index (BMI) Change |
1.51; 0.91 | — |
| PRIMARY Body Mass Index |
34.27; 34.71; 33.58; 34.16; 33.21; 33.92 | — |
| SECONDARY Parent Weight |
99.18; 100.62; 97.39; 98.51; 98.50; 96.06 | — |
| SECONDARY Parent Weight Change |
-1.20; -3.47; -0.32; 0.49 | — |
| SECONDARY Physical Activity |
11.99; 11.92; 21.05; 22.51; 12.03; 12.41 | — |
| SECONDARY Physical Activity Change |
-3.21; 3.24; -1.28; -3.68 | — |
| SECONDARY Physical Activity Energy Expenditure |
915.73; 897.27; 1486.38; 1506.10; 815.05; 856.47 | — |
| SECONDARY Physical Activity Energy Expenditure Change |
10.30; 67.74; 9.57; -36.39 | — |
| SECONDARY Dietary Intake |
1830; 1807; 1699; 1817; 1539; 1502 | — |
| SECONDARY Home Food Environment |
22.16; 22.28; 15.89; 18.54; 15.97; 17.09 | — |
| SECONDARY Parent Reported Parenting Style |
4.08; 4.12; 4.07; 4.10; 4.12; 4.15 | — |
| SECONDARY Role Modeling |
2.54; 2.57; 2.46; 2.52; 2.33; 2.46 | — |
| SECONDARY Restrictive Child Feeding Practices |
3.54; 3.64; 3.36; 3.34; 3.17; 3.23 | — |
| SECONDARY Overall Weight Control Practices |
1.23; 1.12; 1.35; 1.22; 2.25; 2.22 | — |
| SECONDARY Self Monitoring Weight Control Practices |
0.61; 0.52; 0.76; 0.53; 2.29; 2.25 | — |
| SECONDARY Dietary Choices Weight Control Practices |
1.90; 1.84; 2.22; 2.27; 2.65; 2.65 | — |
| SECONDARY Physical Activity Weight Control Practices |
1.09; 0.91; 1.13; 0.86; 1.95; 1.88 | — |
| SECONDARY Psychological Coping Weight Control Practices |
1.31; 1.21; 1.28; 1.20; 2.12; 2.09 | — |
| SECONDARY Adolescent Reported Responsiveness Parenting Style |
27.59; 28.09; 28.00; 28.84; 28.84; 29.12 | — |
| SECONDARY Adolescent Reported Demandingness Parenting Style |
21.78; 21.59; 22.11; 21.87; 22.31; 21.75 | — |
| SECONDARY Adolescent Reported Authoritative Parenting Style |
49.37; 49.68; 50.11; 50.70; 51.15; 50.87 | — |
| SECONDARY Home Exercise Environment |
11.51; 11.11; 13.66; 12.74; 13.02; 12.23 | — |
| SECONDARY Monitoring Child Feeding Practices |
3.30; 3.21; 3.77; 3.41; 3.55; 3.25 | — |
Summary
A randomized control trial to compare the efficacy of two distinct parent treatments on weight loss maintenance for adolescents with obesity participating in a lifestyle intervention including nutrition education, exercise and behavioral support.
Funding support from NIH via 1R01HD095910
Eligibility Criteria
Inclusion Criteria
Adolescent Inclusion Criteria:
- BMI ≥ 85th percentile for age and gender according to the CDC Growth Charts
- Age 12 to 16
- Must reside with the primary participating parent
Parent Inclusion Criteria:
- ≥18
- BMI ≥ 25 kg/m2
- Must reside with the adolescent
Exclusion Criteria
Adolescent Exclusion Criteria:
- Non-English speaking
- Medical condition(s) that may be associated with unintentional weight change
- Diabetes mellitus
- Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
- Use of a GLP-1 within 6 months of study participation
- Use of Depo-Provera within 6 months of study participation
- Medical condition(s) that may be negatively impacted by exercise
- Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
- Reports of compensatory behaviors in the past 3 months
- Current pregnancy or plan to become pregnant during study period
- Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304
- Current participation in another weight loss program
- Personal history of weight loss surgery
- Severe depression
- Clinically significant eating disorder
- Change in dose of metformin, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
- Admission to a psychiatric hospital within the past year
Parent Exclusion Criteria:
- Non-English speaking
- Medical condition(s) that may be associated with unintentional weight change
- Use of oral glucocorticoids, atypical antipsychotics, weight loss medications, or an investigational medication within 3 months of study participation
- Use of a GLP-1 within 6 months of study participation with no T2D diagnosis; if T2D diagnosis, change in dose GLP-1 within 3 months of study participation
- Use of Depo-Provera within 6 months of study participation
- Psychiatric, cognitive, physical or developmental conditions that would impair the ability to complete assessments, participate in a group, or conduct physical activity
- Reports of compensatory behaviors in the past 3 months
- Current pregnancy, lactation, less than 6 months post-partum, or plan to become pregnant during study period
- Previous participation in HM20010365, HM20003076, HM20005235 or HM20014304
- Current participation in another weight loss program
- Personal history of weight loss surgery
- Severe depression
- Clinically significant eating disorder
- Change in dose of diabetes medications, tricyclic antidepressants, selective serotonin uptake inhibitors, or stimulant medications within 3 months of study participation
- Admission to a psychiatric hospital within the past year
Data sourced from ClinicalTrials.gov (NCT03851796). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.